These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

178 related articles for article (PubMed ID: 17125204)

  • 1. In silico prediction of blood-brain barrier permeation using the calculated molecular cross-sectional area as main parameter.
    Gerebtzoff G; Seelig A
    J Chem Inf Model; 2006; 46(6):2638-50. PubMed ID: 17125204
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Validation of topochemical models for the prediction of permeability through the blood-brain barrier.
    Dureja H; Madan AK
    Acta Pharm; 2007 Dec; 57(4):451-67. PubMed ID: 18165189
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Blood-brain barrier permeation: molecular parameters governing passive diffusion.
    Fischer H; Gottschlich R; Seelig A
    J Membr Biol; 1998 Oct; 165(3):201-11. PubMed ID: 9767674
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Surface activity profiling of drugs applied to the prediction of blood-brain barrier permeability.
    Suomalainen P; Johans C; Söderlund T; Kinnunen PK
    J Med Chem; 2004 Mar; 47(7):1783-8. PubMed ID: 15027870
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Predictive model of blood-brain barrier penetration of organic compounds.
    Ma XL; Chen C; Yang J
    Acta Pharmacol Sin; 2005 Apr; 26(4):500-12. PubMed ID: 15780201
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Prediction of blood-brain barrier penetration of poorly soluble drug candidates using surface activity profiling.
    Petereit AC; Swinney K; Mensch J; Mackie C; Stokbroekx S; Brewster M; Dressman JB
    Eur J Pharm Biopharm; 2010 Aug; 75(3):405-10. PubMed ID: 20332025
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Determination of octanol/water partition coefficients for long-chain homologs of orcinol from cereal grains.
    Kozubek A
    Acta Biochim Pol; 1995; 42(2):247-51. PubMed ID: 8588472
    [TBL] [Abstract][Full Text] [Related]  

  • 8. A simple predictive model for blood-brain barrier penetration.
    Fu XC; Song ZF; Fu CY; Liang WQ
    Pharmazie; 2005 May; 60(5):354-8. PubMed ID: 15918585
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Prediction of blood-brain partitioning and human serum albumin binding based on COSMO-RS sigma-moments.
    Wichmann K; Diedenhofen M; Klamt A
    J Chem Inf Model; 2007; 47(1):228-33. PubMed ID: 17238268
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Halogenation of drugs enhances membrane binding and permeation.
    Gerebtzoff G; Li-Blatter X; Fischer H; Frentzel A; Seelig A
    Chembiochem; 2004 May; 5(5):676-84. PubMed ID: 15122640
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Predicting blood-brain barrier penetration of drugs by polar molecular surface area and molecular volume.
    Fu XC; Chen CX; Liang WQ; Yu QS
    Acta Pharmacol Sin; 2001 Jul; 22(7):663-8. PubMed ID: 11749834
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Predicting blood-brain barrier penetration from molecular weight and number of polar atoms.
    Fu XC; Wang GP; Shan HL; Liang WQ; Gao JQ
    Eur J Pharm Biopharm; 2008 Oct; 70(2):462-6. PubMed ID: 18632257
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Modulation of the partition coefficient between octanol and buffer at pH 7.4 and pKa to achieve the optimum balance of blood clearance and volume of distribution for a series of tetrahydropyran histamine type 3 receptor antagonists.
    Hay T; Jones R; Beaumont K; Kemp M
    Drug Metab Dispos; 2009 Sep; 37(9):1864-70. PubMed ID: 19546239
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Why are some properties more difficult to predict than others? A study of QSPR models of solubility, melting point, and Log P.
    Hughes LD; Palmer DS; Nigsch F; Mitchell JB
    J Chem Inf Model; 2008 Jan; 48(1):220-32. PubMed ID: 18186622
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Predicting the brain-penetrating capability of histaminergic compounds.
    Calder JA; Ganellin CR
    Drug Des Discov; 1994 Jun; 11(4):259-68. PubMed ID: 7727679
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Application of ALOGPS 2.1 to predict log D distribution coefficient for Pfizer proprietary compounds.
    Tetko IV; Poda GI
    J Med Chem; 2004 Nov; 47(23):5601-4. PubMed ID: 15509156
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Predicting blood-brain barrier penetration of drugs using an artificial neural network.
    Fu XC; Wang GP; Liang WQ; Yu QS
    Pharmazie; 2004 Feb; 59(2):126-30. PubMed ID: 15025181
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Topochemical models for the prediction of permeability through blood-brain barrier.
    Dureja H; Madan AK
    Int J Pharm; 2006 Oct; 323(1-2):27-33. PubMed ID: 16815653
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Rapidly profiling blood-brain barrier penetration with liposome EKC.
    Wang Y; Sun J; Liu H; He Z
    Electrophoresis; 2007 Jul; 28(14):2391-5. PubMed ID: 17578839
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Predicting penetration across the blood-brain barrier from simple descriptors and fragmentation schemes.
    Zhao YH; Abraham MH; Ibrahim A; Fish PV; Cole S; Lewis ML; de Groot MJ; Reynolds DP
    J Chem Inf Model; 2007; 47(1):170-5. PubMed ID: 17238262
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.